首页 > 最新文献

Movement Disorders最新文献

英文 中文
Morphological Changes in Direct Pathway Striatal Neurons in a Rat Model of Tardive Dyskinesia 迟发性运动障碍大鼠直接通路纹状体神经元形态学改变
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-02 DOI: 10.1002/mds.70068
Hiroki Hikichi, Haruo Nishijima, Fumiaki Mori, Iku Kinoshita, Chieko Suzuki, Koichi Wakabayashi, Masahiko Tomiyama
BackgroundTardive dyskinesia (TD) and drug‐induced parkinsonism (DIP) arise from prolonged dopamine antagonist use. Although D2 receptor hypersensitivity in the indirect pathway is a proposed mechanism, the role of the direct pathway remains unclear.ObjectivesTo investigate morphological changes in the direct pathway striatal neurons' axon terminals in a rat model of haloperidol‐induced TD and DIP.MethodsMale Wistar rats received haloperidol decanoate or placebo over 6 months. Behavioral tests assessed TD‐ and DIP‐like symptoms. Axon terminals forming synapses on dendrites in the internal (GPi) and external (GPe) segments of the globus pallidus were analyzed using electron and immunoelectron microscopy.ResultsHaloperidol‐treated rats exhibited both TD‐ and DIP‐like behaviors. Vesicular gamma‐aminobutyric acid (GABA) transporter (VGAT)‐positive terminals were selectively enlarged in the GPi, and substance P colocalization indicated a direct pathway origin.ConclusionsStructural alterations in direct pathway nerve terminals may contribute to TD, challenging conventional models that focus solely on the indirect pathway. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
迟发性运动障碍(TD)和药物性帕金森病(DIP)是由长期使用多巴胺拮抗剂引起的。虽然间接途径中的D2受体超敏反应是一种被提出的机制,但直接途径的作用尚不清楚。目的观察氟哌啶醇诱导大鼠TD和DIP模型直接通路纹状体神经元轴突末端的形态学变化。方法小型Wistar大鼠分别给予癸酸氟哌啶醇或安慰剂治疗6个月。行为测试评估了TD -和DIP -样症状。利用电子显微镜和免疫电镜对苍白球内节段和外节段树突上形成突触的轴突末梢进行了分析。结果沙哌啶醇处理大鼠表现出TD -和DIP -样行为。囊泡γ -氨基丁酸(GABA)转运蛋白(VGAT)阳性末端在GPi中选择性扩增,P物质共定位表明了直接的途径起源。直接通路神经末梢的结构改变可能导致TD,挑战了仅关注间接通路的传统模型。©2025作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Morphological Changes in Direct Pathway Striatal Neurons in a Rat Model of Tardive Dyskinesia","authors":"Hiroki Hikichi, Haruo Nishijima, Fumiaki Mori, Iku Kinoshita, Chieko Suzuki, Koichi Wakabayashi, Masahiko Tomiyama","doi":"10.1002/mds.70068","DOIUrl":"https://doi.org/10.1002/mds.70068","url":null,"abstract":"BackgroundTardive dyskinesia (TD) and drug‐induced parkinsonism (DIP) arise from prolonged dopamine antagonist use. Although D2 receptor hypersensitivity in the indirect pathway is a proposed mechanism, the role of the direct pathway remains unclear.ObjectivesTo investigate morphological changes in the direct pathway striatal neurons' axon terminals in a rat model of haloperidol‐induced TD and DIP.MethodsMale Wistar rats received haloperidol decanoate or placebo over 6 months. Behavioral tests assessed TD‐ and DIP‐like symptoms. Axon terminals forming synapses on dendrites in the internal (GPi) and external (GPe) segments of the globus pallidus were analyzed using electron and immunoelectron microscopy.ResultsHaloperidol‐treated rats exhibited both TD‐ and DIP‐like behaviors. Vesicular gamma‐aminobutyric acid (GABA) transporter (VGAT)‐positive terminals were selectively enlarged in the GPi, and substance <jats:italic>P</jats:italic> colocalization indicated a direct pathway origin.ConclusionsStructural alterations in direct pathway nerve terminals may contribute to TD, challenging conventional models that focus solely on the indirect pathway. © 2025 The Author(s). <jats:italic>Movement Disorders</jats:italic> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"94 7 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145203251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
September Infographic 9月信息
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-01 DOI: 10.1002/mds.29857

Low/high multi-frequency stimulation of the subthalamic nucleus improves verbal fluency maintaining motor control in Parkinson's Disease

丘脑底核的低/高多频刺激改善帕金森病患者的语言流畅性,维持运动控制
{"title":"September Infographic","authors":"","doi":"10.1002/mds.29857","DOIUrl":"https://doi.org/10.1002/mds.29857","url":null,"abstract":"<p>\u0000 \u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure>\u0000 Low/high multi-frequency stimulation of the subthalamic nucleus improves verbal fluency maintaining motor control in Parkinson's Disease</p>","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 9","pages":""},"PeriodicalIF":7.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Movement Disorders: Volume 40, Number 9, September 2025 运动障碍:第40卷,第9号,2025年9月
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-01 DOI: 10.1002/mds.70038
{"title":"Movement Disorders: Volume 40, Number 9, September 2025","authors":"","doi":"10.1002/mds.70038","DOIUrl":"https://doi.org/10.1002/mds.70038","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 9","pages":""},"PeriodicalIF":7.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mds.70038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Microglia Replacement in CSF1R-RD: Current Evidence and Future Priorities” 回复:“CSF1R-RD小胶质细胞替代:当前证据和未来重点”。
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70054
Hemmo A.F. Yska MD, Stéphanie Nguyen MD, PhD, Marianne Golse MD, Fanny Mochel MD, PhD, Violetta Zujovic PhD
{"title":"Reply to: “Microglia Replacement in CSF1R-RD: Current Evidence and Future Priorities”","authors":"Hemmo A.F. Yska MD,&nbsp;Stéphanie Nguyen MD, PhD,&nbsp;Marianne Golse MD,&nbsp;Fanny Mochel MD, PhD,&nbsp;Violetta Zujovic PhD","doi":"10.1002/mds.70054","DOIUrl":"10.1002/mds.70054","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 10","pages":"2291-2292"},"PeriodicalIF":7.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens” 回复:“早期印度人帕金森氏症的发病:一个基因-环境视角的案例”。
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70053
Asha Kishore MD, DM, Rupam Borgohain DM, Divya Kalikavil Puthenveedu MD, DM, Roopa Rajan MD, DM, Pramod Kumar Pal MD, DM, Rukmini-Mridula Kandadai MD, DM, Ravi Yadav MD, DM, Sahil Mehta MD, DM, Hrishikesh Kumar MD, DM, Niraj Kumar MD, DM, Prashanth Lingappa Kukkle DM, Soaham Desai MD, DM, Kuldeep Shetty MD, DM, Pettarusp Murzban Wadia MD, DM, Annu Aggarwal MD, DM, Pankaj Ashok Agarwal MD, DM, Mirza Masoom Abbas MD, DM, Syam Krishnan MD, DM, Divya M. Radhakrishnan MD, DM, Gurusidheswar Mahadevappa Wali MD, DM, Achal Srivastava MD, DM, Nitish Kamble MD, DM, Teresa Maria D'Costa Ferreira MD, DM, Vivek Lal MD, DM, Ashwin Ashok Kumar Sreelatha MSc, MTech, Luis-Giraldo Gonzalez-Ricardo PhD, Manas Chacko MPH, Manu Sharma PhD
{"title":"Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens”","authors":"Asha Kishore MD, DM,&nbsp;Rupam Borgohain DM,&nbsp;Divya Kalikavil Puthenveedu MD, DM,&nbsp;Roopa Rajan MD, DM,&nbsp;Pramod Kumar Pal MD, DM,&nbsp;Rukmini-Mridula Kandadai MD, DM,&nbsp;Ravi Yadav MD, DM,&nbsp;Sahil Mehta MD, DM,&nbsp;Hrishikesh Kumar MD, DM,&nbsp;Niraj Kumar MD, DM,&nbsp;Prashanth Lingappa Kukkle DM,&nbsp;Soaham Desai MD, DM,&nbsp;Kuldeep Shetty MD, DM,&nbsp;Pettarusp Murzban Wadia MD, DM,&nbsp;Annu Aggarwal MD, DM,&nbsp;Pankaj Ashok Agarwal MD, DM,&nbsp;Mirza Masoom Abbas MD, DM,&nbsp;Syam Krishnan MD, DM,&nbsp;Divya M. Radhakrishnan MD, DM,&nbsp;Gurusidheswar Mahadevappa Wali MD, DM,&nbsp;Achal Srivastava MD, DM,&nbsp;Nitish Kamble MD, DM,&nbsp;Teresa Maria D'Costa Ferreira MD, DM,&nbsp;Vivek Lal MD, DM,&nbsp;Ashwin Ashok Kumar Sreelatha MSc, MTech,&nbsp;Luis-Giraldo Gonzalez-Ricardo PhD,&nbsp;Manas Chacko MPH,&nbsp;Manu Sharma PhD","doi":"10.1002/mds.70053","DOIUrl":"10.1002/mds.70053","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 10","pages":"2287-2288"},"PeriodicalIF":7.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence. 迷走神经刺激在运动障碍中的作用,从原理到证据的系统回顾。
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70044
Francesca Proietti,Matteo Maria Ottaviani,Elisabetta Burchi,Giorgio Vivacqua,Gaia Anzini,Riccardo Antonio Ricciuti,Fioravante Capone,Vaughan G Macefield,Vincenzo Di Lazzaro,Massimo Marano
BACKGROUNDThe vagus nerve (VN), the principal component of the parasympathetic branch of the autonomic nervous system (ANS), mediates bidirec communication between the central nervous system (CNS) and peripheral organs. Vagus nerve stimulation (VNS), delivered through invasive (iVNS) or non-invasive (transcutaneous cervical [tcVNS] and transcutaneous auricular [taVNS]), exerts multimodal effects on multiple circuits and neurotransmitters, and is currently under investigation in movement disorders.OBJECTIVESThis systematic review evaluates the therapeutic potential of VNS in movement disorders (MDs), with a focus on Parkinson's disease (PD), parkinsonism, tremor and essential tremor (ET), cervical dystonia (CD), and Tourette's syndrome (TS).METHODSA systematic search of PubMed, Web of Science, and Scopus was conducted for studies published between 2020 and 2025, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines.RESULTSThirty-two studies met the inclusion criteria: 22 on PD or parkinsonism (14 clinical and 8 preclinical on PD, 1 clinical on multisystem atrophy), 6 on tremor and ET (4 clinical, 2 preclinical), 2 clinical studies on CD, and 1 clinical study on TS. Across conditions, VNS was reported to improve motor and non-motor, enhance synaptic plasticity, modulate neurotransmitter activity relevant to MDs (GABA, norepinephrine, dopamine, and acetylcholine), and reduce neuroinflammation.CONCLUSIONSCurrent evidence supports the multimodal effect of VNS in MDs, particularly in PD, where the most consistent benefits were observed. Non-invasive taVNS represents a promising, safer alternative to iVNS. Larger randomized controlled trials with standardized protocols are needed to validate efficacy, optimize stimulation parameters, and determine long-term clinical and biological impact. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
迷走神经(VN)是自主神经系统(ANS)副交感神经分支的主要组成部分,介导中枢神经系统(CNS)和外周器官之间的双向交流。迷走神经刺激(VNS),通过侵入性(iVNS)或非侵入性(经皮颈[tcVNS]和经皮耳[taVNS])传递,对多个回路和神经递质产生多模态效应,目前正在运动障碍的研究中。目的:本系统综述评估VNS在运动障碍(MDs)中的治疗潜力,重点关注帕金森病(PD)、帕金森病、震颤和特发性震颤(ET)、宫颈肌张力障碍(CD)和妥瑞特综合征(TS)。方法系统检索PubMed、Web of Science和Scopus,检索2020年至2025年间发表的研究,遵循系统评价和元分析2020指南的首选报告项目。结果32项研究符合纳入标准,其中PD或帕金森22项(PD临床14项,临床前8项,多系统萎缩1项),震颤和ET 6项(临床4项,临床前2项),CD 2项,TS 1项。在不同条件下,VNS均能改善运动和非运动,增强突触可塑性,调节与MDs相关的神经递质(GABA、去甲肾上腺素、多巴胺、乙酰胆碱)活性,减轻神经炎症。目前的证据支持VNS在MDs中的多模态效应,特别是在PD中,其中观察到最一致的益处。无创taVNS是iVNS的一种有前途的、更安全的替代方法。需要采用标准化方案的更大规模随机对照试验来验证疗效,优化刺激参数,并确定长期临床和生物学影响。©2025作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence.","authors":"Francesca Proietti,Matteo Maria Ottaviani,Elisabetta Burchi,Giorgio Vivacqua,Gaia Anzini,Riccardo Antonio Ricciuti,Fioravante Capone,Vaughan G Macefield,Vincenzo Di Lazzaro,Massimo Marano","doi":"10.1002/mds.70044","DOIUrl":"https://doi.org/10.1002/mds.70044","url":null,"abstract":"BACKGROUNDThe vagus nerve (VN), the principal component of the parasympathetic branch of the autonomic nervous system (ANS), mediates bidirec communication between the central nervous system (CNS) and peripheral organs. Vagus nerve stimulation (VNS), delivered through invasive (iVNS) or non-invasive (transcutaneous cervical [tcVNS] and transcutaneous auricular [taVNS]), exerts multimodal effects on multiple circuits and neurotransmitters, and is currently under investigation in movement disorders.OBJECTIVESThis systematic review evaluates the therapeutic potential of VNS in movement disorders (MDs), with a focus on Parkinson's disease (PD), parkinsonism, tremor and essential tremor (ET), cervical dystonia (CD), and Tourette's syndrome (TS).METHODSA systematic search of PubMed, Web of Science, and Scopus was conducted for studies published between 2020 and 2025, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines.RESULTSThirty-two studies met the inclusion criteria: 22 on PD or parkinsonism (14 clinical and 8 preclinical on PD, 1 clinical on multisystem atrophy), 6 on tremor and ET (4 clinical, 2 preclinical), 2 clinical studies on CD, and 1 clinical study on TS. Across conditions, VNS was reported to improve motor and non-motor, enhance synaptic plasticity, modulate neurotransmitter activity relevant to MDs (GABA, norepinephrine, dopamine, and acetylcholine), and reduce neuroinflammation.CONCLUSIONSCurrent evidence supports the multimodal effect of VNS in MDs, particularly in PD, where the most consistent benefits were observed. Non-invasive taVNS represents a promising, safer alternative to iVNS. Larger randomized controlled trials with standardized protocols are needed to validate efficacy, optimize stimulation parameters, and determine long-term clinical and biological impact. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"65 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal Blood-Biomarker-Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance-Guided Focused Ultrasound. 基于纵向血液生物标志物的脑损伤评估患者接受深部脑刺激和磁共振引导聚焦超声。
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70071
Justina Dargvainiene,Ann-Kristin Helmers,Juliana Naumann,Carl Alexander Gless,Bettina Möller,Julius Welzel,Frank Leypoldt,Johannes Hensler,Ina Tesseur,Klaus-Peter Wandinger,Günther Deuschl,Daniela Berg,Steffen Paschen
BACKGROUNDDeep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) are associated with neuroaxonal damage and astroglial activation; yet their extent and timing remain unclear despite clinical relevance for monitoring and outcome assessment.OBJECTIVEThis study assessed neuroaxonal damage and astroglial activation after DBS (n = 21) and MRgFUS (n = 19) reflected by serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP).METHODSSamples were collected at baseline, 24 h, 7 days, and 3/6/9 months posttreatment. Biomarker levels were measured using a single-molecule array (Simoa).RESULTSsNfL peaked at day 7 and sGFAP at 24 h post-intervention in both groups. sNfL normalized at 6 months in DBS and 3 months in MRgFUS. sGFAP normalized within 7 days in both groups. Biomarker elevations were higher in DBS patients.CONCLUSIONSDBS and MRgFUS cause transient neuroaxonal injury and astroglial activation, with greater extent in DBS. Biomarker monitoring suggests final clinical evaluation should be performed 6 months after treatment at the earliest. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
脑深部刺激(DBS)和磁共振引导聚焦超声(MRgFUS)与神经轴突损伤和星形胶质细胞激活有关;尽管监测和结果评估具有临床意义,但其范围和时间仍不清楚。目的通过血清神经丝轻链(sNfL)和血清胶质纤维酸性蛋白(sGFAP)来评估DBS (n = 21)和MRgFUS (n = 19)后的神经轴突损伤和星形胶质细胞激活情况。方法分别于治疗后基线、24 h、7 d和3/6/9个月采集样本。使用单分子阵列(Simoa)测量生物标志物水平。结果两组患者snfl在干预后第7天达到峰值,sGFAP在干预后24 h达到峰值。在DBS和MRgFUS中,sNfL在6个月和3个月时恢复正常。两组sGFAP均在7天内恢复正常。DBS患者的生物标志物升高更高。结论DBS和MRgFUS可引起短暂性神经轴突损伤和星形胶质细胞激活,且DBS损伤程度更大。生物标志物监测表明,最终临床评估应在治疗后6个月进行。©2025作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Longitudinal Blood-Biomarker-Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance-Guided Focused Ultrasound.","authors":"Justina Dargvainiene,Ann-Kristin Helmers,Juliana Naumann,Carl Alexander Gless,Bettina Möller,Julius Welzel,Frank Leypoldt,Johannes Hensler,Ina Tesseur,Klaus-Peter Wandinger,Günther Deuschl,Daniela Berg,Steffen Paschen","doi":"10.1002/mds.70071","DOIUrl":"https://doi.org/10.1002/mds.70071","url":null,"abstract":"BACKGROUNDDeep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) are associated with neuroaxonal damage and astroglial activation; yet their extent and timing remain unclear despite clinical relevance for monitoring and outcome assessment.OBJECTIVEThis study assessed neuroaxonal damage and astroglial activation after DBS (n = 21) and MRgFUS (n = 19) reflected by serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP).METHODSSamples were collected at baseline, 24 h, 7 days, and 3/6/9 months posttreatment. Biomarker levels were measured using a single-molecule array (Simoa).RESULTSsNfL peaked at day 7 and sGFAP at 24 h post-intervention in both groups. sNfL normalized at 6 months in DBS and 3 months in MRgFUS. sGFAP normalized within 7 days in both groups. Biomarker elevations were higher in DBS patients.CONCLUSIONSDBS and MRgFUS cause transient neuroaxonal injury and astroglial activation, with greater extent in DBS. Biomarker monitoring suggests final clinical evaluation should be performed 6 months after treatment at the earliest. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"19 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens 早期印第安人帕金森氏症的发病:一个基因-环境透镜的案例
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70055
Halil Onder MD, Zeynep Pekgoz MD, Mehmet Fevzi Oztekin MD
{"title":"Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens","authors":"Halil Onder MD,&nbsp;Zeynep Pekgoz MD,&nbsp;Mehmet Fevzi Oztekin MD","doi":"10.1002/mds.70055","DOIUrl":"10.1002/mds.70055","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 10","pages":"2285-2286"},"PeriodicalIF":7.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microglia Replacement in CSF1R-RD: Current Evidence and Future Priorities CSF1R-RD的小胶质细胞替代:目前的证据和未来的重点。
IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70050
Tomasz Chmiela MD, PhD, Zbiegniew K. Wszolek MD
{"title":"Microglia Replacement in CSF1R-RD: Current Evidence and Future Priorities","authors":"Tomasz Chmiela MD, PhD,&nbsp;Zbiegniew K. Wszolek MD","doi":"10.1002/mds.70050","DOIUrl":"10.1002/mds.70050","url":null,"abstract":"","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"40 10","pages":"2289-2290"},"PeriodicalIF":7.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Long-Read Nanopore Sequencing for Precision Resolution of Genomic Variants in Dystonia. 整合长读纳米孔测序用于肌张力障碍基因组变异的精确解析。
IF 8.6 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-09-30 DOI: 10.1002/mds.70072
Ugo Sorrentino,Martin Pavlov,Nazanin Mirza-Schreiber,Melanie Brugger,Theresa Brunet,Eugenia Tsoma,Alice Saparov,Ivana Dzinovic,Philip Harrer,Antonia M Stehr,Matias Wagner,Erik Tilch,Barbara Wallacher,Shiraz Alhasan,Anne Koy,Alessio Di Fonzo,Miriam Kolnikova,Katarina Kusikova,Petra Havrankova,Raushana Tautanova,Sandy Lösecke,Sebastian Eck,Sylvia Boesch,Jan Necpal,Matej Skorvanek,Robert Jech,Holger Prokisch,Juliane Winkelmann,Konrad Oexle,Elisabeth Graf,Michael Zech
BACKGROUNDAlthough many individuals with dystonia present with features indicative of single-gene etiologies, obtaining definitive genetic diagnoses can be challenging.OBJECTIVEWe assessed the value of nanopore-based long-read sequencing (LRS) in achieving molecular clarification of dystonic syndromes.METHODSFrom a large dystonia cohort with short-read sequencing (SRS) data, 14 cases with unclear, difficult-to-evaluate, or missing causative variants were recruited. Long-read whole-genome sequencing was performed according to Oxford Nanopore Technologies (ONT) protocols.RESULTSONT sequencing produced long-range haplotypes, variant calls inaccessible to short-read technology, as well as methylation data. Phase inference allowed for changes in variant classification, establishing compound heterozygosity of causative variants in four cases. We illustrate an important advantage of LRS compared with SRS in (re)defining the identity of dystonia-causing structural variants and repeat expansions for seven individuals. One patient was found to harbor a novel exonic LINE-1 insertion in SGCE, expanding the genetic mechanism in myoclonus-dystonia. ONT data also provided unexpected insights into apparent mosaic expanded repeats in FMR1 in a subject with isolated focal dystonia. We further showed that LRS outperformed SRS in avoiding erroneous calls resulting from confounding pseudogene sequences and in discovering pathogenic alterations missed by conventional pipeline utilization (three cases). Moreover, simultaneous methylome analysis aided in directing the interpretation of three variants, including a KMT2B variant of uncertain significance that was reclassified as causal by LRS-based episignature profiling.CONCLUSIONSONT-based LRS uniquely improves analysis of dystonia-associated variations that had not previously been resolved by SRS, implying broad utility for future exploration of the molecular origins of the condition. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
背景:尽管许多肌张力障碍患者具有单基因病因的特征,但获得明确的遗传诊断可能具有挑战性。目的评估基于纳米孔的长读测序(LRS)在实现张力障碍综合征的分子澄清中的价值。方法从一个具有短读测序(SRS)数据的大型肌张力障碍队列中,招募了14例病因变异不明确、难以评估或缺失的病例。根据牛津纳米孔技术(ONT)协议进行长读全基因组测序。结果测序产生了远程单倍型,短读技术无法获得的变异呼叫,以及甲基化数据。相位推断允许变异分类的变化,在四种情况下建立了致病变异的复合杂合性。我们说明了LRS与SRS相比的一个重要优势,即(重新)定义了7个人的肌张力障碍引起的结构变异和重复扩张的身份。一名患者在SGCE中发现了一个新的外显子LINE-1插入,扩展了肌阵挛-肌张力障碍的遗传机制。ONT数据也提供了在孤立局灶性肌张力障碍患者的FMR1中明显的马赛克扩展重复序列的意想不到的见解。我们进一步表明,LRS在避免混淆假基因序列导致的错误呼叫和发现传统管道利用遗漏的致病性改变(3例)方面优于SRS。此外,同时进行的甲基组分析有助于指导对三种变体的解释,包括一种不确定意义的KMT2B变体,该变体被基于lrs的表观特征分析重新归类为因果关系。结论基于sont的LRS独特地改善了SRS未解决的肌张力障碍相关变异的分析,为未来探索该疾病的分子起源提供了广泛的应用。©2025作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
{"title":"Integrating Long-Read Nanopore Sequencing for Precision Resolution of Genomic Variants in Dystonia.","authors":"Ugo Sorrentino,Martin Pavlov,Nazanin Mirza-Schreiber,Melanie Brugger,Theresa Brunet,Eugenia Tsoma,Alice Saparov,Ivana Dzinovic,Philip Harrer,Antonia M Stehr,Matias Wagner,Erik Tilch,Barbara Wallacher,Shiraz Alhasan,Anne Koy,Alessio Di Fonzo,Miriam Kolnikova,Katarina Kusikova,Petra Havrankova,Raushana Tautanova,Sandy Lösecke,Sebastian Eck,Sylvia Boesch,Jan Necpal,Matej Skorvanek,Robert Jech,Holger Prokisch,Juliane Winkelmann,Konrad Oexle,Elisabeth Graf,Michael Zech","doi":"10.1002/mds.70072","DOIUrl":"https://doi.org/10.1002/mds.70072","url":null,"abstract":"BACKGROUNDAlthough many individuals with dystonia present with features indicative of single-gene etiologies, obtaining definitive genetic diagnoses can be challenging.OBJECTIVEWe assessed the value of nanopore-based long-read sequencing (LRS) in achieving molecular clarification of dystonic syndromes.METHODSFrom a large dystonia cohort with short-read sequencing (SRS) data, 14 cases with unclear, difficult-to-evaluate, or missing causative variants were recruited. Long-read whole-genome sequencing was performed according to Oxford Nanopore Technologies (ONT) protocols.RESULTSONT sequencing produced long-range haplotypes, variant calls inaccessible to short-read technology, as well as methylation data. Phase inference allowed for changes in variant classification, establishing compound heterozygosity of causative variants in four cases. We illustrate an important advantage of LRS compared with SRS in (re)defining the identity of dystonia-causing structural variants and repeat expansions for seven individuals. One patient was found to harbor a novel exonic LINE-1 insertion in SGCE, expanding the genetic mechanism in myoclonus-dystonia. ONT data also provided unexpected insights into apparent mosaic expanded repeats in FMR1 in a subject with isolated focal dystonia. We further showed that LRS outperformed SRS in avoiding erroneous calls resulting from confounding pseudogene sequences and in discovering pathogenic alterations missed by conventional pipeline utilization (three cases). Moreover, simultaneous methylome analysis aided in directing the interpretation of three variants, including a KMT2B variant of uncertain significance that was reclassified as causal by LRS-based episignature profiling.CONCLUSIONSONT-based LRS uniquely improves analysis of dystonia-associated variations that had not previously been resolved by SRS, implying broad utility for future exploration of the molecular origins of the condition. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"7 1","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Movement Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1